Lexington biopharmaceutical company receives federal, state grants

Lexington-based Transposagen Biopharmaceuticals, which creates genetically modified laboratory rats, said Tuesday that it has received more than $395,000 in federal and state funding to continue its research.

If the grant's aims are proven, the company could receive additional federal dollars to create thousands of lines of the rates, which mimic human disease and assist in drug development.